Author(s):
Rana Khuder, Nouma Hasan, Mazen Salloum, Suzan Al-shamali, Nader Abedallaa
Email(s):
rana.khuder97@gmail.com
DOI:
10.52711/0974-360X.2024.00723 
Address:
Rana Khuder*1, Nouma Hasan2, Mazen Salloum3, Suzan Al-shamali4, Nader Abedallaa5
1Master Student At Pharmacology and Toxicology Department, Faculty of Pharmacy, Tishreen University, Latakia, Syria.
2PhD in Pharmacology, Pharmacology and Toxicology Department, Faculty of Pharmacy, Tishreen University, Latakia, Syria.
3PhD in Microbiology, Al Hawash Private University, Homs, Syria.
4PhD in Immunology, Laboratory Diagnosis Department, Faculty of Medicine, Tishreen University, Latakia, Syria.
5Professor, Oncology Department, Faculty of Medicine, Tishreen University, Latakia, Syria.
*Corresponding Author
Published In:
Volume - 17,
Issue - 10,
Year - 2024
ABSTRACT:
Colorectal cancer is among the top three most prevalent cancers globally. The situation in Syria mirrors the world statistics and colorectal cancer is the third most common cancer in Syria in both males and females. MTHFR gene, also known as 5,10-methylenetetrahydrofolate reductase gene is located on chromosome1.MTHFR is a main enzyme in folate metabolism. The A1298C polymorphism is in exon 7 of MTHFR gene, leads to a glutamate to alanine replacement at codon 429, this polymorphism lies in the C-terminal end of the enzyme. The study aimed to determine the prevalence and association of A1298C polymorphism with risk of colorectal cancer. RT-PCR was used to identify the genotypes. The results showed that 62% of colorectal cancer patients had AA (wild type) genotype, 26% of the patients had AC (heterozygote) and 12% had CC (mutant), while 40% of healthy individuals had AA genotype, 30% had AC and 30% had CC. The analysis revealed no significant association between the A1298C polymorphism and risk of colorectal cancer (P value>0.05).We furtherdetermined the association of each genotype with risk of colon cancer alone and with rectal cancer alone.The analysis demonstratedthat CC genotype is a protective factor against colon cancer (OR=0.140, CI=95%, P value =0.033). However, no association between A1298C and the risk of rectal cancer(P value>0.05) was found.In conclusion, the A1298C polymorphism might be associated with reduced risk of colon cancer. Nevertheless, this genetic polymorphism might have no effect on the risk ofrectal cancer
Cite this article:
Rana Khuder, Nouma Hasan, Mazen Salloum, Suzan Al-shamali, Nader Abedallaa. Prevalence and Association of MTHFR A1298C Polymorphism with risk of Colorectal cancer in Syrian patients. Research Journal of Pharmacy and Technology. 2024; 17(10):4694-8. doi: 10.52711/0974-360X.2024.00723
Cite(Electronic):
Rana Khuder, Nouma Hasan, Mazen Salloum, Suzan Al-shamali, Nader Abedallaa. Prevalence and Association of MTHFR A1298C Polymorphism with risk of Colorectal cancer in Syrian patients. Research Journal of Pharmacy and Technology. 2024; 17(10):4694-8. doi: 10.52711/0974-360X.2024.00723 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2024-17-10-8
REFERENCES:
1. Mahendiran, S., et al. Evaluation of Anticancer Effects of Vasopressin Receptor blocker in Colon Cancer-An In vitro Study. Research Journal of Pharmacy and Technology. 2020; 13: 77. DOI: 10.5958/0974-360X.2020.00014.1.
2. Archana, R.D. Physical Characterization, Solubility test, and Dissolution test of the Solid Dispersion System of the Andrographolide-chitosan system for effective treatment against colon cancer. Research Journal of Pharmacy and Technology. 2024; 17(2). DOI: https://doi.org/10.52711/0974-360X.2024.00139.
3. Anon, B., et al. A study of the association between UGT1A1*28 variant allele of UGT1A1 gene and colonic phenotype of sporadic colorectal cancer. Dig Liver Dis. 2019; 51(4): 579-583. DOI: 10.1016/j.dld.2018.11.032.
4. Rajalekshmi, M., et al. The Review on Genetics, Epigenetics, Risk Factors and Diagnosis of Colon Cancer. Research Journal of Pharmacy and Technology. 2018; 11: 5147. DOI: 10.5958/0974-360X.2018.00940.X.
5. WHO. WHO Syrian Arab Republic fact sheet 2020. 2020;
6. Li, L., et al. Educational level and colorectal cancer risk: the mediating roles of lifestyle and dietary factors. European Journal of Cancer Prevention. 2022; 31(2): 137-144. DOI: 10.1097/cej.0000000000000697.
7. Lewandowska, A., et al. Risk Factors for the Diagnosis of Colorectal Cancer. Cancer Control. 2022; 29. 10732748211056692. DOI: 10.1177/10732748211056692.
8. Hua, H., et al. Risk factors for early-onset colorectal cancer: systematic review and meta-analysis. Frontiers in Oncology. 2023. 13. DOI: 10.3389/fonc.2023.1132306.
9. Teng, Z., et al. The 677C>T (rs1801133) polymorphism in the MTHFR gene contributes to colorectal cancer risk: a meta-analysis based on 71 research studies. PLoS One. 2013; 8(2): e55332. DOI: 10.1371/journal.pone.0055332.
10. Ryan, B.M. and D.G. Weir. Relevance of folate metabolism in the pathogenesis of colorectal cancer. J Lab Clin Med. 2001; 138(3): 164-76. DOI: 10.1067/mlc.2001.117161.
11. Blount, B.C., et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci. 1997; 94(7): 3290-5. DOI: 10.1073/pnas.94.7.3290.
12. Raghubeer, S. and T.E. Matsha. Methylenetetrahydrofolate (MTHFR), the One-Carbon Cycle, and Cardiovascular Risks. Nutrients. 2021: 13(12). DOI: 10.3390/nu13124562.
13. Lak, R., et al. Association analysis of C677T and A1298C polymorphisms in MTHFR gene in patients with colorectal cancer susceptibility. Central Asian Journal of Medical and Pharmaceutical Sciences Innovation. 2021; 1(2): 74-80.
14. Fernández-Peralta, A.M., et al. Association of polymorphisms MTHFR C677T and A1298C with risk of colorectal cancer, genetic and epigenetic characteristic of tumors, and response to chemotherapy. Int J Colorectal Dis. 2010; 25(2): 141-51. DOI: 10.1007/s00384-009-0779-y.
15. Younes, A., et al. Prevalence of MTHFR Gene (C677T and A1298C) Polymorphism in the Syrian Coastal Area. Research Journal of Pharmacy and Technology. 2023: 4365-4369. DOI: 10.52711/0974-360X.2023.00714.
16. Hale, N. and D. Minzola. Methylenetetrahydrofolate Reductase Deficiency: A Case Report. AANA journal, 2020; 88: 303-306.
17. Goyal, S., et al. Vascular Endothelial Dysfunction: Complication of Diabetes Mellitus and Hyperhomocysteinemia. Research J. Pharm. and Tech. 2010; 3: 657.
18. Teguh Satrio, P.W., Muhamad Robiul Fuadi, Hendri Susilo, Atika. Association between Homocysteine Level and Vitamin D Deficiency with Acute Coronary Syndrome in Indonesia. Research Journal of Pharmacy and Technology. 2024. 17(2). DOI: 10.52711/0974-360X.2024.00108.
19. Rai, V., et al. Methylenetetrahydrofolate reductase A1298C genetic variant and risk of schizophrenia: A meta-analysis. Indian J Med Res. 2017; 145(4): 437-447. DOI: 10.4103/ijmr.IJMR_745_14.
20. Mir, Z., et al. Synergistic Molecular Effect of BDNF, Apo E and MTHFR in inducing Depression in Alzheimer's Disease. Research Journal of Pharmacy and Technology. 2018; 11: 4317. DOI: 10.5958/0974-360X.2018.00790.4.
21. Ulrich, C.M., et al. Thymidylate synthase promoter polymorphism, interaction with folate intake, and risk of colorectal adenomas. Cancer Res. 2002; 62(12): 3361-4.
22. Wiik, M.U., et al. MTHFR C677T and A1298C polymorphism’s effect on risk of colorectal cancer in Lynch syndrome. Scientific Reports. 2023; 13(1): 18783. DOI: 10.1038/s41598-023-44120-8.
23. Zhu, X.L., et al. Association between the MTHFR A1298C polymorphism and risk of cancer: evidence from 265 case-control studies. Mol Genet Genomics. 2016; 291(1): 51-63. DOI: 10.1007/s00438-015-1082-y.
24. Elkhateeb, W., et al. Molecular Identification, Metabolites profiling, Anti-breast cancer, Anti-colorectal cancer, and antioxidant potentials of Streptomyces zaomyceticus AA1 isolated from a remote bat cave in Egypt. Research Journal of Pharmacy and Technology. 2020; 13: 3072-3080. DOI: 10.5958/0974-360X.2020.00545.4.
25. Sanganna, B. and A.R. Kulkarni. Antioxidant and anti-colon cancer activity of fruit peel of citrus reticulate essential oil on HT-29 cell line. Research Journal of Pharmacy and Technology. 2013. 6: 216-219.
26. Patel, S., M. Sinha, and M. Mitra. Glutathione-S-transferase M1 and T1 gene Polymorphism as Risk Factors of Oral Squamous Cell Carcinoma: A Preliminary Investigation. Research Journal of Pharmacy and Technology. 2012; 5.
27. Eva Kholifah, N.I. Anticancer activity of Acmella uliginosa against WiDr colon cancer cell line and T47D breast cancer cell line. Research Journal of Pharmacy and Technology. 2023; 16(2). DOI: https://doi.org/10.52711/0974-360X.2023.00109.
28. Young-In, K. Role of Folate in Colon Cancer Development and Progression. The Journal of Nutrition. 2003; 133(11): 3731S-3739S. DOI: https://doi.org/10.1093/jn/133.11.3731S.
29. Paschke, S., et al. Are Colon and Rectal Cancer Two Different Tumor Entities? A Proposal to Abandon the Term Colorectal Cancer. Int J Mol Sci. 2018; 19(9). DOI: 10.3390/ijms19092577.
30. Keku, T., et al. 5,10-Methylenetetrahydrofolate reductase codon 677 and 1298 polymorphisms and colon cancer in African Americans and whites. Cancer Epidemiol Biomarkers Prev. 2002. 11(12): 1611-21.
31. JingWen, W.J.W., et al. Associations between 5, 10-methylenetetrahydrofolate reductase codon 677 and 1298 genetic polymorphisms and environmental factors with reference to susceptibility to colorectal cancer: a case-control study in an Indian population. International Journal of Cancer. 118(4): 991–997.